As all forms of HMGA2 transcript exhibit similar transformative potential, it can be hypothesized that a single regulatory regimen could chiefly govern the misexpression of these different transcript types and their propensity to drive the pathogenesis of benign mesenchymal tumors [18]. The gene discussed is HMGA2; the disease is mesenchymal cell neoplasm.